Doximity Change in Assets/Liabilities 2020-2024 | DOCS
Doximity annual/quarterly change in assets/liabilities history and growth rate from 2020 to 2024. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
- Doximity change in assets/liabilities for the quarter ending December 31, 2024 was $-0.020B, a 61.5% decline year-over-year.
- Doximity change in assets/liabilities for the twelve months ending December 31, 2024 was $-0.034B, a 56.57% decline year-over-year.
- Doximity annual change in assets/liabilities for 2024 was $-0.037B, a 781.88% decline from 2023.
- Doximity annual change in assets/liabilities for 2023 was $0.005B, a 130.06% decline from 2022.
- Doximity annual change in assets/liabilities for 2022 was $-0.018B, a 172.57% decline from 2021.
| Doximity Annual Change in Assets/Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $-37 |
| 2023 | $5 |
| 2022 | $-18 |
| 2021 | $25 |
| 2020 | $1 |
| 2019 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.934B | $0.475B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.529B | 24.94 |
| Elevance Health (ELV) | United States | $96.108B | 12.88 |
| CVS Health (CVS) | United States | $84.839B | 12.41 |
| Cencora (COR) | United States | $55.604B | 20.18 |
| DiDi Global (DIDIY) | China | $20.317B | 29.86 |
| Natera (NTRA) | United States | $20.018B | 0.00 |
| BioMerieux (BMXMF) | France | $15.594B | 0.00 |
| Solventum (SOLV) | United States | $11.463B | 10.69 |
| ICON (ICLR) | Ireland | $11.251B | 10.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
| Revvity (RVTY) | United States | $11.032B | 18.74 |
| CochLear (CHEOY) | Australia | $10.876B | 0.00 |
| Avantor (AVTR) | United States | $10.289B | 15.10 |
| Viatris (VTRS) | United States | $9.024B | 2.85 |
| Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
| Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
| HealthEquity (HQY) | United States | $7.311B | 35.97 |
| Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
| Sotera Health (SHC) | United States | $2.975B | 17.18 |
| BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
| Organon (OGN) | United States | $2.868B | 2.92 |
| Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
| GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
| Concentras Parent (CON) | United States | $2.613B | 13.59 |
| Progyny (PGNY) | United States | $1.837B | 40.45 |
| Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
| Premier (PINC) | United States | $1.765B | 11.30 |
| GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
| Agilon Health (AGL) | United States | $1.649B | 0.00 |
| PACS (PACS) | United States | $1.411B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 16.62 |
| Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.824B | 16.14 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
| Embecta (EMBC) | United States | $0.659B | 4.52 |
| Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
| QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.417B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.388B | 36.57 |
| InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
| LifeMD (LFMD) | United States | $0.242B | 0.00 |
| DocGo (DCGO) | United States | $0.216B | 8.83 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| Oncology Institute (TOI) | United States | $0.163B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
| Beauty Health (SKIN) | United States | $0.106B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 4.93 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |